Sign In
Buy PDS
$95.01
+1.95 (+2.10%)
At Close: Jun 03, 2026
Is Precision Drilling (PDS) Stock Undervalued Right Now?
10:40am, Tuesday, 10'th Feb 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are These 4 Energy Stocks Set to Beat Q4 Earnings Estimates?
09:50am, Tuesday, 10'th Feb 2026
Here is a look at what to expect from energy stocks, like AR, NBR, TTE and PDS, ahead of their quarterly earnings reports, set to be released tomorrow.
Earnings Preview: Precision Drilling (PDS) Q4 Earnings Expected to Decline
11:01am, Wednesday, 04'th Feb 2026
Precision Drilling (PDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate Cancer
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
08:45am, Thursday, 22'nd Jan 2026
Patent Enhances IP Estate for Lead Asset; Combined with Anticipated Biologics Exclusivity, Market Protections Extend Over 20 Years Patent Enhances IP Estate for Lead Asset; Combined with Anticipated B
Precision Drilling Corporation 2025 Fourth Quarter and Year-End Results Conference Call and Webcast
04:30pm, Monday, 05'th Jan 2026
CALGARY, Alberta, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) intends to release its 2025 fourth quarter and year-end results after the market closes on Wednesday, Feb
Precision Drilling (NYSE:PDS) Share Price Passes Above 200-Day Moving Average – Here’s Why
02:56am, Tuesday, 30'th Dec 2025
Precision Drilling Corporation (NYSE: PDS - Get Free Report) (TSE: PD) shares passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $57.11 and tra
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
08:00am, Tuesday, 09'th Dec 2025
New Patent Grants Broad Composition Claims for PDS0101 Previously Granted Patent Protections and Anticipated Market Exclusivity Provide Protection for PDS0101 in the United States into the 2040s PRINC
Arrowstreet Capital Limited Partnership Raises Stock Holdings in Precision Drilling Corporation $PDS
03:26am, Monday, 08'th Dec 2025
Arrowstreet Capital Limited Partnership raised its stake in Precision Drilling Corporation (NYSE: PDS) (TSE: PD) by 275.5% during the undefined quarter, according to its most recent disclosure with th
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
08:30am, Tuesday, 02'nd Dec 2025
Company to Discuss Proposed Amendment to Phase 3 VERSATILE-003 Trial Enabling Potential Accelerated Approval Pathway Company to Discuss Proposed Amendment to Phase 3 VERSATILE-003 Trial Enabling Poten
Brokerages Set Precision Drilling Co. (TSE:PD) PT at C$102.00
01:12am, Saturday, 29'th Nov 2025
Precision Drilling Co. (TSE: PD - Get Free Report) (NYSE: PDS) has been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat r
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
07:30am, Thursday, 13'th Nov 2025
Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Cancer
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
03:31pm, Tuesday, 11'th Nov 2025
PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how
Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms natural killer (NK) cells to possess characteristics
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
08:00am, Thursday, 06'th Nov 2025
PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how
